应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06667 美因基因
耶稣受难节休市 03-28 16:08:03
10.020
+0.930
+10.23%
最高
10.020
最低
8.900
成交量
1.50万
今开
8.990
昨收
9.090
日振幅
12.32%
总市值
23.72亿
流通市值
23.72亿
总股本
2.37亿
成交额
13.81万
换手率
0.01%
流通股本
2.37亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
美因基因盘中异动 临近收盘股价大涨6.93%报9.721港元
自选股智能写手 · 03-28 15:55
美因基因盘中异动 临近收盘股价大涨6.93%报9.721港元
《公司业绩》美因基因(06667.HK)去年亏转盈赚3,004万元人民币
阿斯达克财经 · 03-27 09:22
《公司业绩》美因基因(06667.HK)去年亏转盈赚3,004万元人民币
美因基因发布2023年度业绩 净利润3003.8万元同比扭亏为盈
新浪港股 · 03-27 08:50
美因基因发布2023年度业绩 净利润3003.8万元同比扭亏为盈
美因基因(06667.HK)年度实现营业收入1.51亿元 同比增长3.8%
格隆汇资讯 · 03-26 23:08
美因基因(06667.HK)年度实现营业收入1.51亿元 同比增长3.8%
美因基因(06667)发布2023年度业绩,净利润3003.8万元,同比扭亏为盈
智通财经 · 03-26 22:55
美因基因(06667)发布2023年度业绩,净利润3003.8万元,同比扭亏为盈
美因基因盘中异动 临近收盘急速拉升5.47%报8.671港元
自选股智能写手 · 03-22
美因基因盘中异动 临近收盘急速拉升5.47%报8.671港元
美因基因(06667)3月20日注销122.44万股已回购股份
智通财经 · 03-20
美因基因(06667)3月20日注销122.44万股已回购股份
美因基因(06667)股价下跌5.111%,现价港币$8.54
阿斯达克财经 · 03-18
美因基因(06667)股价下跌5.111%,现价港币$8.54
美因基因盘中异动 股价大跌5.12%报8.540港元
自选股智能写手 · 03-18
美因基因盘中异动 股价大跌5.12%报8.540港元
美因基因盘中异动 早盘股价大涨5.88%
自选股智能写手 · 03-15
美因基因盘中异动 早盘股价大涨5.88%
美因基因(06667.HK)拟3月26日举行董事会会议批准全年业绩
格隆汇资讯 · 03-14
美因基因(06667.HK)拟3月26日举行董事会会议批准全年业绩
美因基因(06667)下跌5.76%,报8.51元/股
金融界 · 03-13
美因基因(06667)下跌5.76%,报8.51元/股
美因基因盘中异动 下午盘大幅跳水5.08%
自选股智能写手 · 03-13
美因基因盘中异动 下午盘大幅跳水5.08%
美因基因(06667)上涨5.57%,报9.28元/股
金融界 · 03-12
美因基因(06667)上涨5.57%,报9.28元/股
美因基因盘中异动 快速拉升5.24%
自选股智能写手 · 03-12
美因基因盘中异动 快速拉升5.24%
美因基因(06667)下跌6.33%,报9.32元/股
金融界 · 03-04
美因基因(06667)下跌6.33%,报9.32元/股
美因基因盘中异动 大幅跳水5.62%报9.391港元
自选股智能写手 · 03-04
美因基因盘中异动 大幅跳水5.62%报9.391港元
美因基因(06667)股价下跌5.628%,现价港币$9.39
阿斯达克财经 · 03-04
美因基因(06667)股价下跌5.628%,现价港币$9.39
美因基因(06667)下跌17.26%,报9.83元/股
金融界 · 03-01
美因基因(06667)下跌17.26%,报9.83元/股
美因基因(06667)股价显著下跌14.141%,现价港币$10.2
阿斯达克财经 · 03-01
美因基因(06667)股价显著下跌14.141%,现价港币$10.2
公司概况
公司名称:
美因基因
所属市场:
SEHK
上市日期:
--
主营业务:
美因基因有限公司是一家主要从事基因检测的中国控股公司。该公司通过三个部门开展其业务。消费级基因检测服务部门提供营养与代谢检测、癌症风险评估、慢性疾病易感性、药物遗传学检测及传染病检测。癌症筛查服务部门提供Septin9结直肠癌筛查检测、黏结蛋白聚糖2(SDC2)结直肠癌筛查检测及基因环指蛋白180(RNF180)/Septin9胃癌筛查检测。其他服务部门主要向第三方研究机构提供基因研究与分析服务。
发行价格:
--
{"stockData":{"symbol":"06667","market":"HK","secType":"STK","nameCN":"美因基因","latestPrice":10.02,"timestamp":1711613283021,"preClose":9.09,"halted":0,"volume":15000,"delay":0,"floatShares":236764800,"shares":236764800,"eps":0.15296392,"marketStatus":"耶稣受难节休市","marketStatusCode":7,"change":0.93,"latestTime":"03-28 16:08:03","open":8.99,"high":10.02,"low":8.9,"amount":138130,"amplitude":0.123212,"askPrice":10.02,"askSize":3000,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.1529639266910821,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1712021400000},"adr":0,"listingDate":1655827200000,"adjPreClose":9.09,"openAndCloseTimeList":[[1711589400000,1711598400000],[1711602000000,1711612800000]],"volumeRatio":0.41713014448911845,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06667/wiki","defaultTab":"wiki","newsList":[{"id":"2422130199","title":"美因基因盘中异动 临近收盘股价大涨6.93%报9.721港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422130199","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422130199?lang=zh_cn&edition=full","pubTime":"2024-03-28 15:55","pubTimestamp":1711612557,"startTime":"0","endTime":"0","summary":"2024年03月28日临近收盘15时55分,美因基因股票出现异动,股价急速上涨6.93%。截至发稿,该股报9.721港元/股,成交量1.16万股,换手率0.00%,振幅9.02%。美因基因股票所在的生物技术行业中,整体涨幅为1.06%。其中消费级基因检测服务及癌症筛查服务于截至2023年12月31日止年度所产生的收入分别为人民币1.08亿元及人民币0.43亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032815555787e7cb3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032815555787e7cb3c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422060917","title":"《公司业绩》美因基因(06667.HK)去年亏转盈赚3,004万元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2422060917","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422060917?lang=zh_cn&edition=full","pubTime":"2024-03-27 09:22","pubTimestamp":1711502520,"startTime":"0","endTime":"0","summary":"美因基因(06667.HK) 公布截至去年12月底止全年业绩,营业额1.51亿元人民币(下同),按年升3.8%。亏转盈赚3,003.8万元,上年同期蚀1,761.8万元;每股盈利0.14元。不派末期息。(gc/w)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2023/08/30中期业绩无派息2023/03/31末期业绩无派息 2022/08/30中期业绩无派息 AASTOCKS新闻","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220623142715024_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220623142715024_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1337451/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2422603164","title":"美因基因发布2023年度业绩 净利润3003.8万元同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2422603164","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2422603164?lang=zh_cn&edition=full","pubTime":"2024-03-27 08:50","pubTimestamp":1711500617,"startTime":"0","endTime":"0","summary":"美因基因(06667)公布截至2023年12月31日止年度业绩,该集团录得收入1.51亿元人民币,同比增长3.8%,净利润3003.8万元人民币,同比扭亏为盈。基本每股盈利0.14元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-27/doc-inaptkkx5794115.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-27/doc-inaptkkx5794115.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422610601","title":"美因基因(06667.HK)年度实现营业收入1.51亿元 同比增长3.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422610601","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2422610601?lang=zh_cn&edition=full","pubTime":"2024-03-26 23:08","pubTimestamp":1711465707,"startTime":"0","endTime":"0","summary":"格隆汇3月26日丨美因基因(06667.HK)发布公告,截至2023年12月31日止年度,公司实现营业收入人民币151.3百万元,同比增长3.8%;若不考虑新冠检测服务的影响,营业收入同比增长16.8%。实现净利润人民币30.0百万元,2022年同期亏损为人民币17.6百万元,2023年扭亏为盈,净利润较2022年增长人民币47.6百万元;主要由于公司于报告期内践行更为积极的市场策略,加快销售渠道拓展,丰富产品矩阵,不断优化基因检测服务的产品结构,同时加大成本控制及应收账款的催收力度,净利润大幅增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032623083487b810c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032623083487b810c7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422617504","title":"美因基因(06667)发布2023年度业绩,净利润3003.8万元,同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2422617504","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422617504?lang=zh_cn&edition=full","pubTime":"2024-03-26 22:55","pubTimestamp":1711464952,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美因基因(06667)公布截至2023年12月31日止年度业绩,该集团录得收入1.51亿元人民币,同比增长3.8%,净利润3003.8万元人民币,同比扭亏为盈。基本每股盈利0.14元。截至2023年12月31日止年度,收入增幅为3.8%;若不考虑新冠检测服务的影响,收入增幅为16.8%。其中消费级基因检测服务及癌症筛查服务于截至2023年12月31日止年度所产生的收入分别为人民币1.08亿元及人民币0.43亿元。收入同比增长,主要由于公司于报告期内践行更为积极的市场策略,加快销售渠道拓展,丰富产品矩阵,不断优化基因检测服务的产品结构致使收入同比稳步增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1092925.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2421868339","title":"美因基因盘中异动 临近收盘急速拉升5.47%报8.671港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421868339","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421868339?lang=zh_cn&edition=full","pubTime":"2024-03-22 15:33","pubTimestamp":1711092780,"startTime":"0","endTime":"0","summary":"2024年03月22日临近收盘15时33分,美因基因股票出现波动,股价大幅上涨5.47%。截至发稿,该股报8.671港元/股,成交量3.1万股,换手率0.01%,振幅6.33%。资金方面,该股资金流入1.2054万港元,流出24.4734万港元。美因基因股票所在的生物技术行业中,整体跌幅为2.23%。其相关个股中,宜明昂科-B、华康生物医学、美因基因涨幅较大,振幅较大的相关个股有宜明昂科-B、药明巨诺-B、奥星生命科技,振幅分别为37.16%、19.70%、14.84%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322153300861e0636&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322153300861e0636&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420691714","title":"美因基因(06667)3月20日注销122.44万股已回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2420691714","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2420691714?lang=zh_cn&edition=full","pubTime":"2024-03-20 18:42","pubTimestamp":1710931353,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美因基因(06667)发布公告,该公司于2024年3月20日注销122.44万股已回购股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1089199.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2420412079","title":"美因基因(06667)股价下跌5.111%,现价港币$8.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2420412079","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2420412079?lang=zh_cn&edition=full","pubTime":"2024-03-18 14:32","pubTimestamp":1710743520,"startTime":"0","endTime":"0","summary":"[下跌股]美因基因(06667) 股价在下午02:32比前收市价下跌5.111%,现股价为港币$8.54。至目前为止,今日最高价为$8.99,而最低价为$8.54。总成交量为4.7万股,总成交金额为港币$40.977万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2403181131/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2420412051","title":"美因基因盘中异动 股价大跌5.12%报8.540港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420412051","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420412051?lang=zh_cn&edition=full","pubTime":"2024-03-18 14:32","pubTimestamp":1710743520,"startTime":"0","endTime":"0","summary":"2024年03月18日下午盘14时32分,美因基因股票出现波动,股价大幅下挫5.12%。截至发稿,该股报8.540港元/股,成交量4.42万股,换手率0.02%,振幅4.78%。资金方面,该股资金流入40.9774万港元,流出0港元。美因基因股票所在的生物技术行业中,整体涨幅为0.06%。其相关个股中,腾盛博药-B、贝康医疗-B、荣昌生物涨幅较大,振幅较大的相关个股有奥星生命科技、药明合联、嘉和生物-B,振幅分别为20.44%、13.19%、12.40%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318143201861df042&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318143201861df042&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419991175","title":"美因基因盘中异动 早盘股价大涨5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419991175","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419991175?lang=zh_cn&edition=full","pubTime":"2024-03-15 11:15","pubTimestamp":1710472508,"startTime":"0","endTime":"0","summary":"2024年03月15日早盘11时15分,美因基因股票出现异动,股价急速拉升5.88%。截至发稿,该股报9.001港元/股,成交量4.32万股,换手率0.02%,振幅5.88%。美因基因股票所在的生物技术行业中,整体跌幅为1.30%。其相关个股中,圣诺医药-B、绿竹生物-B、美因基因涨幅较大,振幅较大的相关个股有圣诺医药-B、宜明昂科-B、科笛-B,振幅分别为19.03%、17.05%、13.33%。美因基因公司简介:美因基因有限公司是一家主要从事基因检测的中国控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031511150987e79311&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031511150987e79311&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419262404","title":"美因基因(06667.HK)拟3月26日举行董事会会议批准全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2419262404","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2419262404?lang=zh_cn&edition=full","pubTime":"2024-03-14 16:53","pubTimestamp":1710406395,"startTime":"0","endTime":"0","summary":"格隆汇3月14日丨美因基因(06667.HK)公布,董事会通告谨定于2024年3月26日(星期二)举行董事会会议,以考虑及通过集团截至2023年12月31日止年度的全年业绩公告及其发布,建议末期股息(如有),以及处理其他事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403141653238b31f2cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403141653238b31f2cb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419575642","title":"美因基因(06667)下跌5.76%,报8.51元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2419575642","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2419575642?lang=zh_cn&edition=full","pubTime":"2024-03-13 15:36","pubTimestamp":1710315390,"startTime":"0","endTime":"0","summary":"3月13日,美因基因(06667)盘中下跌5.76%,截至15:36,报8.51元/股,成交101.4万元。美因基因有限公司主要业务是提供消费级基因检测和癌症筛查服务,是中国最大的消费级基因检测平台和癌症筛查基因检测平台。截至2021年6月30日,公司已进行超过10百万次基因检测,2020年平均每月进行逾230,000次。截至2023年中报,美因基因营业总收入9887.9万元、净利润3511.7万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/13153639835043.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2419233522","title":"美因基因盘中异动 下午盘大幅跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419233522","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419233522?lang=zh_cn&edition=full","pubTime":"2024-03-13 14:27","pubTimestamp":1710311266,"startTime":"0","endTime":"0","summary":"2024年03月13日下午盘14时27分,美因基因股票出现波动,股价急速下跌5.08%。截至发稿,该股报8.571港元/股,成交量6.02万股,换手率0.03%,振幅5.65%。美因基因股票所在的生物技术行业中,整体涨幅为0.05%。其相关个股中,科伦博泰生物-B、迈博药业-B、和誉-B涨幅较大,振幅较大的相关个股有科伦博泰生物-B、圣诺医药-B、宜明昂科-B,振幅分别为20.31%、16.31%、13.29%。其他服务部门主要向第三方研究机构提供基因研究与分析服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313142746861ddcc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313142746861ddcc0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418058293","title":"美因基因(06667)上涨5.57%,报9.28元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2418058293","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2418058293?lang=zh_cn&edition=full","pubTime":"2024-03-12 15:20","pubTimestamp":1710228026,"startTime":"0","endTime":"0","summary":"3月12日,美因基因(06667)盘中上涨5.57%,截至15:20,报9.28元/股,成交101.31万元。美因基因有限公司主要业务是提供消费级基因检测和癌症筛查服务,是中国最大的消费级基因检测平台和癌症筛查基因检测平台。截至2021年6月30日,公司已进行超过10百万次基因检测,2020年平均每月进行逾230,000次。截至2023年中报,美因基因营业总收入9887.9万元、净利润3511.7万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/12152039817074.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2418737666","title":"美因基因盘中异动 快速拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418737666","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418737666?lang=zh_cn&edition=full","pubTime":"2024-03-12 13:17","pubTimestamp":1710220632,"startTime":"0","endTime":"0","summary":"2024年03月12日下午盘13时17分,美因基因股票出现异动,股价快速上涨5.24%。截至发稿,该股报9.251港元/股,成交量3.66万股,换手率0.02%,振幅4.89%。美因基因股票所在的生物技术行业中,整体涨幅为1.69%。其相关个股中,嘉和生物-B、欧康维视生物-B、锦欣生殖涨幅较大,振幅较大的相关个股有来凯医药-B、宜明昂科-B、基石药业-B,振幅分别为18.58%、15.11%、11.58%。其他服务部门主要向第三方研究机构提供基因研究与分析服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403121317127a4bd133&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403121317127a4bd133&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416164529","title":"美因基因(06667)下跌6.33%,报9.32元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2416164529","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2416164529?lang=zh_cn&edition=full","pubTime":"2024-03-04 15:15","pubTimestamp":1709536543,"startTime":"0","endTime":"0","summary":"3月4日,美因基因(06667)盘中下跌6.33%,截至15:15,报9.32元/股,成交101.27万元。美因基因有限公司主要业务是提供消费级基因检测和癌症筛查服务,是中国最大的消费级基因检测平台和癌症筛查基因检测平台。截至2021年6月30日,公司已进行超过10百万次基因检测,2020年平均每月进行逾230,000次。截至2023年中报,美因基因营业总收入9887.9万元、净利润3511.7万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/04151539719870.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2416168899","title":"美因基因盘中异动 大幅跳水5.62%报9.391港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416168899","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416168899?lang=zh_cn&edition=full","pubTime":"2024-03-04 13:32","pubTimestamp":1709530322,"startTime":"0","endTime":"0","summary":"2024年03月04日下午盘13时32分,美因基因股票出现异动,股价急速下跌5.62%。截至发稿,该股报9.391港元/股,成交量4.94万股,换手率0.02%,振幅5.63%。资金方面,该股资金流入46.8716万港元,流出5718港元。美因基因股票所在的生物技术行业中,整体涨幅为2.94%。其相关个股中,药明合联、科伦博泰生物-B、来凯医药-B涨幅较大,振幅较大的相关个股有基石药业-B、加科思-B、腾盛博药-B,振幅分别为33.78%、31.32%、29.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403041332027916f02d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403041332027916f02d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416016168","title":"美因基因(06667)股价下跌5.628%,现价港币$9.39","url":"https://stock-news.laohu8.com/highlight/detail?id=2416016168","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2416016168?lang=zh_cn&edition=full","pubTime":"2024-03-04 13:31","pubTimestamp":1709530260,"startTime":"0","endTime":"0","summary":"[下跌股]美因基因(06667) 股价在下午01:31比前收市价下跌5.628%,现股价为港币$9.39。至目前为止,今日最高价为$9.95,而最低价为$9.39。总成交量为4.94万股,总成交金额为港币$47.443万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2403041170/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2416266657","title":"美因基因(06667)下跌17.26%,报9.83元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2416266657","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2416266657?lang=zh_cn&edition=full","pubTime":"2024-03-01 14:53","pubTimestamp":1709275996,"startTime":"0","endTime":"0","summary":"3月1日,美因基因(06667)盘中下跌17.26%,截至14:53,报9.83元/股,成交100.91万元。美因基因有限公司主要业务是提供消费级基因检测和癌症筛查服务,是中国最大的消费级基因检测平台和癌症筛查基因检测平台。截至2021年6月30日,公司已进行超过10百万次基因检测,2020年平均每月进行逾230,000次。截至2023年中报,美因基因营业总收入9887.9万元、净利润3511.7万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/01145339698793.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2416637460","title":"美因基因(06667)股价显著下跌14.141%,现价港币$10.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2416637460","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2416637460?lang=zh_cn&edition=full","pubTime":"2024-03-01 10:45","pubTimestamp":1709261100,"startTime":"0","endTime":"0","summary":"[下跌股]美因基因(06667) 股价在上午10:45比前收市价显著下跌14.141%,现股价为港币$10.2。至目前为止,今日最高价为$10.2,而最低价为$10.2。总成交量为2200股,总成交金额为港币$2.244万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2403011033/aamm-all-category","is_publish_highlight":false,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.219},{"period":"1month","weight":0.002},{"period":"3month","weight":-0.0272},{"period":"6month","weight":0.2116},{"period":"1year","weight":-0.1241},{"period":"ytd","weight":-0.0272}],"compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0149},{"period":"3month","weight":-0.0297},{"period":"6month","weight":-0.0712},{"period":"1year","weight":-0.1808},{"period":"ytd","weight":-0.0297}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"美因基因有限公司是一家主要从事基因检测的中国控股公司。该公司通过三个部门开展其业务。消费级基因检测服务部门提供营养与代谢检测、癌症风险评估、慢性疾病易感性、药物遗传学检测及传染病检测。癌症筛查服务部门提供Septin9结直肠癌筛查检测、黏结蛋白聚糖2(SDC2)结直肠癌筛查检测及基因环指蛋白180(RNF180)/Septin9胃癌筛查检测。其他服务部门主要向第三方研究机构提供基因研究与分析服务。","exchange":"SEHK","name":"美因基因","nameEN":"MEGA GENOMICS"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美因基因(06667)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美因基因,06667,美因基因股票,美因基因股票老虎,美因基因股票老虎国际,美因基因行情,美因基因股票行情,美因基因股价,美因基因股市,美因基因股票价格,美因基因股票交易,美因基因股票购买,美因基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美因基因(06667)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}